Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tat'iana Iu Semiglazova"'
Autor:
Vera A Gorbunova, Irina V Kolyadina, Elena I Kovalenko, Liudmila V Manziuk, Elena V Artamonova, Liudmila G Zhukova, Larisa V Bolotina, Tat'iana Iu Semiglazova, Aleksei G Manikhas, Natal'ia A Raevskaia, Il'ia M Itkin, Dmitrii V Filonenko, Larisa A Zhilyaeva, Viktor E Gol'dberg, Natal'ia O Popova, Dmitrii M Ponomarenko, Valentina E Shikina, Irina R Suslova, Olga V Romanchuk, Dmitrii V Kozlov, Ali-Dzarakhmat S Rzaev, Vasilii V Marfutov, Irina I Andreiashkina, Liubov' I Vladimirova, Irina S Mitashok, Natal'ia M Tikhanovskaia, Elena V Karabina, Guzel' Z Mukhametshina, Al'fiia I Khasanova, Sufiia Z Safina, Mikhail V Shaidorov, Dmitrii A Morozov, Elena P Prokof'eva, Liudmila V Kramskaia, Tat'iana V Karandeeva, Irina V Evstigneeva, Elena G Ovchinnikova, Tat'iana P Klement'eva, Olga V Khrupalo, Elena V Tiuvinova, Viktor M Sherstnev, Igor' S Chernov, Dzheims Dzh Kolokolov, Elena A Gaisina, Natal'ia V Levchenko, Viacheslav A Chubenko, Anton Iu Povyshev, Inna V Iudina, Liudmila V Vorotilina, Tat'iana V Andreeva, Garnik S Tumanian, Anton E Koziakov, Liudmila A Gil'mutdinova, Mikhail A Osipov, Alina S Shatokhina, Alena A Vazhenina, Angelina S Chichkanova, Vladimir I Vladimirov, Aleksandr N Ivanov, Anna S Belokhvostova, Elena M Cherniakova, Elena A Tul'china, Svetlana A Maklashova, Oksana N Shkodenko, Iuliia V Kostalanova, Anna V Tarasova, Evgeniia S Kuz'mina
Publikováno v:
Современная онкология, Vol 21, Iss 1, Pp 12-23 (2019)
Aim. The aim of the study is to examine the efficacy and safety of eribulin in HER2-negative metastatic breast cancer (BC) in Russian clinical practice. Materials and methods. The analysis included 459 patients with advanced BC from 44 federal and mu
Externí odkaz:
https://doaj.org/article/fab8f79eb72a4ebeb4af3ca5e29be2e9
Autor:
Andrei V. Chernichenko, Iurii M. Bychkov, Aleksandr A. Fedenko, Elena V. Artamonova, Tigran G. Gevorkian, Valeriia V. Mochal’nikova, Gennadii N. Ponomarenko, Zhanna V. Khailova, Sergei A. Ivanov, Svetlana B. Korotkova, Fedor Moiseenko, Irina V. Gridneva, Kristina O. Kondrat’eva, Aleksei V. Smolin, Anton A. Krutov, Tat'iana Iu Semiglazova, Dimitr T. Marinov, Mikhail A. Eremushkin, Sergei V. Miller, Vladimir D. Chkhikvadze, Evgenii O. Rodionov, T. N. Borisova, Sergei N. Novikov, Liubov' I Vladimirova, Denis V. Kovlen, Oleg V. Pikin, Konstantin Laktionov, Aleksei V. Butenko, Marina M. Khulamkhanova, A S Zhabina, Evgenii V. Levchenko, Valerii V. Breder, Igor N. Turkin, Nikita M. Volkov, Dina D. Sakaeva, Margarita A. Zernova, Elena V. Filonenko, Malikhova Oa, Olga A. Obukhova, Anna I. Semenova, Aleksandra M. Stepanova, Sergei A. Tuzikov, Tatiana V. Konchugova, Vladimir M. Sotnikov, Aleksandr E. Kuz’minov, Stepan M. Ergnian, Aleksei A. Nevol’skikh, Ilmira R. Gil’mutdinova, Galina A. Tkachenko, Igor E. Tiurin, Pavel V. Kononets, Boris Kasparov, Konstantin I. Kolbanov, Elena V. Reutova
Publikováno v:
Современная онкология, Vol 23, Iss 3, Pp 369-402 (2021)
Lung cancer has the highest morbidity rate among all malignant tumors in men and the highest mortality rate in men and women in Russia. In total, 49 145 new cases of lung cancer were registered (diagnosed) in Russia in 2019. The majority of cases are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3d13444e2fc18d4a1acc79083addac4
https://doi.org/10.26442/18151434.2021.3.201048
https://doi.org/10.26442/18151434.2021.3.201048
Autor:
Mikhail A Osipov, Iuliia V Kostalanova, Elena Karabina, Vera A Gorbunova, Dmitrii M Ponomarenko, Evgeniia S Kuz'mina, Al'fiia I Khasanova, Elena M Cherniakova, Natalia V Strakhova, Tat'iana V Karandeeva, Natal'ia V Levchenko, Inna P. Ganshina, Guzel' Z Mukhametshina, S V Khokhlova, Mikhail V Shaidorov, Tat'iana Iu Semiglazova, Irina S Bulavina, Liubov' I Vladimirova, Elena V. Artamonova, Dzheims Dzh Kolokolov, Il'ia M Itkin, Alina S Shatokhina, Aleksei G Manikhas, Larisa Bolotina, Natal'ia A Raevskaia, Igor' S Chernov, Oksana N Shkodenko, Dmitrii V Filonenko, N. O. Popova, V E Goldberg, Natal'ia M Tikhanovskaia, Irina V. Kolyadina, Sufiia Z Safina, Andrei E Orlov, Liudmila V Manziuk, Valentina E Shikina, Liudmila G. Zhukova, Irina V. Evstigneeva, Anton Iu Povyshev, Elena I. Kovalenko, Vladislav V Petkau
Publikováno v:
Современная онкология, Vol 21, Iss 2, Pp 17-24 (2019)
Aim. Eribulin is an active cytostatic, associated with a wide range of mechanisms of antitumor effects, but eribulin efficiency and safety in patients with breast cancer (BC), associated with cerebral metastases are still poorly understood. Materials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa692b452669005256eba3db6f5422bd
https://doi.org/10.26442/18151434.2019.2.190395
https://doi.org/10.26442/18151434.2019.2.190395
Autor:
Natal'ia M Tikhanovskaia, Elena Karabina, Igor' S Chernov, Tat'iana V Karandeeva, Mikhail A Osipov, Irina V. Kolyadina, Ali-Dzarakhmat S Rzaev, Dmitrii V. Kozlov, Sufiia Z Safina, Vasilii V. Marfutov, Elena P Prokof'eva, Oksana N Shkodenko, Alena A Vazhenina, Tat'iana V Andreeva, Elena G. Ovchinnikova, Irina R. Suslova, Elena I. Kovalenko, Olga V Khrupalo, Tat'iana Iu Semiglazova, Liudmila V. Vorotilina, Irina I. Andreiashkina, Elena V. Artamonova, Anton Iu Povyshev, Angelina S Chichkanova, Olga V Romanchuk, Vera A Gorbunova, Liubov' I Vladimirova, Elena A. Gaisina, Garnik S Tumanian, Iuliia V Kostalanova, Liudmila A Gil'mutdinova, Irina S Mitashok, Liudmila V Manziuk, Dmitrii M Ponomarenko, Evgeniia S Kuz'mina, Al'fiia I Khasanova, Guzel' Z Mukhametshina, Vladimir I. Vladimirov, Dmitrii A Morozov, Liudmila V. Kramskaia, Mikhail V Shaidorov, V E Goldberg, Inna V Iudina, Valentina E Shikina, Liudmila G. Zhukova, N. O. Popova, Irina V. Evstigneeva, Anton E. Koziakov, Elena A Tul'china, Elena V Tiuvinova, Il'ia M Itkin, Alina S Shatokhina, Aleksei G Manikhas, Dzheims Dzh Kolokolov, Anna S Belokhvostova, Natal'ia V Levchenko, Svetlana A Maklashova, Aleksandr N Ivanov, Larisa Bolotina, Anna V Tarasova, Dmitrii V Filonenko, Viacheslav A. Chubenko, Natal'ia A Raevskaia, Viktor M Sherstnev, Elena M Cherniakova, Tat'iana P Klement'eva, Larisa A Zhilyaeva
Publikováno v:
Современная онкология, Vol 21, Iss 1, Pp 12-23 (2019)
Aim. The aim of the study is to examine the efficacy and safety of eribulin in HER2-negative metastatic breast cancer (BC) in Russian clinical practice. Materials and methods. The analysis included 459 patients with advanced BC from 44 federal and mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a6a2dd4170f83bf2d09813743b639af
https://doi.org/10.26442/18151434.2019.1.190250
https://doi.org/10.26442/18151434.2019.1.190250